x |
| Revenue for Array BioPharma Decreases by -3% even though Revenue for Biotech and Medical Products Industry Increases by 6.6% over Latest 12 Months |
|
Stock Quote: (NGM:ARRY) |
| 11/09/2009 |
|
| 3.28 |
 +0.23 |
+7.54% |
1,427,314 |
|
| Revenue for Array BioPharma Decreases by -3% even though Revenue for Biotech and Medical Products Industry Increases by 6.6% over Latest 12 Months |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, New York, November 9, 2009,T12-NEWS reports that Revenue for Array BioPharma (NASDAQ:ARRY) for its trailing twelve months (TTM) ended September 30, 2009 decreased by -3% to $27,124,000, from ... read full story |
|
|
|
|
